Interstitial lung diseases: never forget to think about it in primary care

Click to increase image sizeClick to decrease image size

Declaration of interest

G Bermudo Peloche has been paid for attending educational activities (Boehringer Ing) in the last past 3 years. M Molina-Molina has received grants and payments for scientific advice (outside this work) from Boehringer Ing, Roche, Ferrer, Chiesi, Veracyte in the past 3 years. M Roman-Rodriguez has been paid to make lectures and educational activities from many different pharmaceutical companies including AstraZeneca, Boehringer Ingelheim, Chiesi, FAES, Gebro, GSK, Menarini and Pfizer: and his institution has received grants for research from Astra Zeneca in the past 3 years. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Reviewer disclosures

Peer reviewers on this manuscript have no relevant financial or other relationships to disclose.

Additional information

Funding

This paper was not funded.